Six startups awarded non-dilutive funding through Paratus Digital Health Accelerator, part of the BARDA Accelerator Network
CHICAGO, IL — MATTER, the premier healthcare incubator and innovation hub, is pleased to announce six startups selected to receive non-dilutive funding through the Paratus Digital Health Accelerator, the digital health hub of the Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network.
These milestone-based projects will support early-stage innovators developing digital health solutions that strengthen U.S. health security, advance clinical care and improve preparedness for chemical, biological, radiological and nuclear (CBRN) incidents, pandemic influenza and emerging infectious diseases. Funding will enable companies to validate clinical, technical or business assumptions; advance technologies toward their next inflection points; and accelerate progress in areas such as medical countermeasure development, diagnostics, clinical decision support and real-world evidence generation.
Over the next several weeks, each startup will execute a time-bound, milestone-driven project and receive access to MATTER’s curated network of mentors, study site partners and industry experts.
Learn about the companies selected for funding:
GiwoTech
GiwoTech is utilizing AI-driven molecular dynamics to create virus digital twins for rapid antiviral drug discovery by modeling viral assembly with atomic precision.
Omphalos Lifesciences
Omphalos is developing an AI-powered digital human platform that simulates real human physiology to enable accurate in silico trials, accelerate drug discovery, and reduce clinical failure rates.
Mye Health
Mye Health is developing remote concussion monitoring through eye movement tracking on smartphones, enabling early detection and continuous monitoring of mTBI and concussions.
Radiolife
Radiolife leverages AI and radio-frequency (RF) technology for reagent-free, rapid detection of pathogens in liquid samples.
Xtory
Xtory is building an AI-powered clinical decision support system that uses large language models and real-time patient data to improve early detection and treatment of sepsis.
Benten Technologies
Benten Technologies is developing SAFE4BOTH, an integrated maternal health platform combining Community Health Workers, wearable technologies, and AI/ML-driven insights to support rural pregnant and parenting women in clinical trials.
Applications for non-dilutive funding now live
The Paratus Digital Health Accelerator is one of five hubs within the BARDA Accelerator Network, which provides comprehensive support to health security innovators and BARDA portfolio companies through accelerator services, technical and business expertise and resources.
Applications are open for the following non-dilutive funding awards:
- Non-dilutive Funding for Traumatic Brain Injury (TBI) Assessment Solutions — Awards ranging from $500,000 to $2,000,000 to support digital health tools that improve diagnosis and triage of suspected traumatic brain injuries as medical consequences of nuclear detonation and related blast events.
- Non-dilutive Funding for Wearable Biosensors — Milestone-based funding awards up to $200,000 to support the development, evaluation and validation of wearable biosensing technologies that detect and monitor diseases such as influenza, other infectious diseases and CBRN threats.
To learn more about the Paratus Digital Health Accelerator and current opportunities, visit matter.health/paratus.
This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00028.